OBJECTIVES: Patients with SSADH deficiency, a disorder of chronically elevated endogenous GABA and GHB, were studied for sleep symptoms and polysomnography. We hypothesized that patients would have excessive daytime somnolence and decreased REM sleep. DESIGN: Polysomnography and MSLT were performed on patients enrolled for comprehensive clinical studies of SSADH deficiency. SETTING: Sleep studies were obtained in the sleep laboratories at CNMC and NIH. PATIENTS: Sleep recordings were obtained in 10 patients with confirmed SSADH deficiency. INTERVENTIONS: Thirteen overnight polysomnograms were obtained in 10 patients (7 male, 3 female, ages 11-27 y). Eleven MSLT studies were completed in 8 patients. MEASUREMENTS AND RESULTS: Polysomnograms showed prolongation of REM stage latency (mean 272 +/- 89 min) and decreased percent stage REM (mean 8.9%, range 0.3% to 13.8%). Decreased mean sleep latency was present in 6 of 11 MSLTs. CONCLUSIONS: SSADH deficiency is associated with prolonged latency to stage REM and decreased percent stage REM. This disorder represents a model of chronic GABA and GHB accumulation associated with suppression of REM sleep.
OBJECTIVES:Patients with SSADH deficiency, a disorder of chronically elevated endogenous GABA and GHB, were studied for sleep symptoms and polysomnography. We hypothesized that patients would have excessive daytime somnolence and decreased REM sleep. DESIGN: Polysomnography and MSLT were performed on patients enrolled for comprehensive clinical studies of SSADH deficiency. SETTING: Sleep studies were obtained in the sleep laboratories at CNMC and NIH. PATIENTS: Sleep recordings were obtained in 10 patients with confirmed SSADH deficiency. INTERVENTIONS: Thirteen overnight polysomnograms were obtained in 10 patients (7 male, 3 female, ages 11-27 y). Eleven MSLT studies were completed in 8 patients. MEASUREMENTS AND RESULTS: Polysomnograms showed prolongation of REM stage latency (mean 272 +/- 89 min) and decreased percent stage REM (mean 8.9%, range 0.3% to 13.8%). Decreased mean sleep latency was present in 6 of 11 MSLTs. CONCLUSIONS:SSADH deficiency is associated with prolonged latency to stage REM and decreased percent stage REM. This disorder represents a model of chronic GABA and GHB accumulation associated with suppression of REM sleep.
Authors: Edward J Novotny; Robert K Fulbright; Phillip L Pearl; K Michael Gibson; Douglas L Rothman Journal: Ann Neurol Date: 2003 Impact factor: 10.422
Authors: P L Pearl; K M Gibson; Z Quezado; I Dustin; J Taylor; S Trzcinski; J Schreiber; K Forester; P Reeves-Tyer; C Liew; S Shamim; P Herscovitch; R Carson; J Butman; C Jakobs; W Theodore Journal: Neurology Date: 2009-08-11 Impact factor: 9.910
Authors: K Michael Gibson; Maneesh Gupta; Phillip L Pearl; Mendel Tuchman; L Gilbert Vezina; O Carter Snead; Leo M E Smit; Cornelis Jakobs Journal: Biol Psychiatry Date: 2003-10-01 Impact factor: 13.382
Authors: Maneesh Gupta; Boris M Hogema; Markus Grompe; Teodoro G Bottiglieri; Alessandra Concas; Giovanni Biggio; Cristiana Sogliano; Antonello E Rigamonti; Phillip L Pearl; O Carter Snead; Cornelis Jakobs; K Michael Gibson Journal: Ann Neurol Date: 2003 Impact factor: 10.422
Authors: T Ethofer; U Seeger; U Klose; M Erb; B Kardatzki; E Kraft; G B Landwehrmeyer; W Grodd; A Storch Journal: Neurology Date: 2004-03-23 Impact factor: 9.910
Authors: K M Gibson; D S M Schor; M Gupta; W S Guerand; H Senephansiri; T G Burlingame; H Bartels; B M Hogema; T Bottiglieri; W Froestl; O C Snead; M Grompe; C Jakobs Journal: J Neurochem Date: 2002-04 Impact factor: 5.372
Authors: Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson Journal: Antioxid Redox Signal Date: 2011-04-10 Impact factor: 8.401
Authors: Janine Reis; Leonardo G Cohen; Phillip L Pearl; Brita Fritsch; Nikolai H Jung; Irene Dustin; William H Theodore Journal: Neurology Date: 2012-06-20 Impact factor: 9.910
Authors: Phillip L Pearl; Mahsa Parviz; Kara Vogel; John Schreiber; William H Theodore; K Michael Gibson Journal: Dev Med Child Neurol Date: 2014-12-29 Impact factor: 5.449
Authors: Mary Kay Koenig; Ryan Hodgeman; James J Riviello; Wendy Chung; Jennifer Bain; Claudia A Chiriboga; Kazushi Ichikawa; Hitoshi Osaka; Megumi Tsuji; K Michael Gibson; Penelope E Bonnen; Phillip L Pearl Journal: Neurology Date: 2017-04-14 Impact factor: 9.910
Authors: Ronak Lakhani; Kara R Vogel; Andreas Till; Jingjing Liu; Sarah F Burnett; K Michael Gibson; Suresh Subramani Journal: EMBO Mol Med Date: 2014-02-27 Impact factor: 12.137